Georgia's Health Minister Mikheil Sarjveladze responded to the protest by parents of children with Duchenne muscular ...
The Speak Foundation today announced the launch of the LGMD Centers of Excellence, a national network of leading academic medical institutions designed to improve coordinated, multidisciplinary care ...
Entos Pharmaceuticals Inc (Entos), a clinical-stage company that develops genetic medicines utilizing its non-viral, redosable Fusogenix PLV delivery platform is proud to announce a collaboration with ...
PHOENIX - We are learning more about the death of comedian Gilbert Gottfried, which was announced on April 12. According to a statement from Gottfried's longtime friend and publicist, Glenn Schwartz, ...
Medera Inc. ("Medera"), a clinical-stage biopharmaceutical company developing next-generation cardiovascular therapeutics, and its clinical development division Sardocor, today announced that the U.S.
Roche Holding said it would start a late-stage study for a gene therapy for Duchenne muscular dystrophy to seek approval in the European Union after drug regulators in the bloc turned it down last ...
Muscle tissue damage appears when muscular dystrophy is induced in a mouse model (middle). But when researchers block the function of two genes that drive unwanted mitochondrial pore formation (right) ...
Muscular dystrophies represent a group of inherited primary diseases of muscle, characterized by muscle fiber degeneration and muscle weakness. Classification of these conditions has traditionally ...
The FDA expanded the approval of delandistrogene moxeparvovec-rokl (Elevidys) gene therapy for Duchenne muscular dystrophy on Thursday to include ambulatory or non-ambulatory patients ages 4 years and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results